Physician profile
Michael Kirk
NPI 1225584204
$2,219.49
in general payments reported to CMS, 2019-2025
18 companies · $61.18 in 2025
The $61.18 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.68 · 2020: $265 · 2021: $355 · 2022: $745 · 2023: $399 · 2024: $365 · 2025: $61.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $517.33 | 2022-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $444.13 | 2022-2025 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $431.09 | 2020-2024 | Farxiga, Airsupra |
| Daiichi Sankyo INC. | $195.88 | 2021-2025 | Injectafer |
| Abbvie INC. | $111.86 | 2021-2023 | |
| Abbott Laboratories | $96.65 | 2022-2023 | Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $55.42 | 2020-2021 | |
| Amgen INC. | $52.88 | 2023-2024 | Repatha, Otezla |
| Xeris Pharmaceuticals, INC. | $51.26 | 2021 | |
| Janssen Pharmaceuticals, INC | $47.56 | 2022 | |
| Pfizer INC. | $37.76 | 2019-2020 | |
| Allergan, INC. | $35.75 | 2020 | |
| Inspire Medical Systems, INC. | $32.37 | 2023 | Inspire |
| Dexcom, INC. | $28.67 | 2021-2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $27.89 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.21 | 2020 | |
| Esperion Therapeutics, INC. | $17.50 | 2020 | |
| Glaxosmithkline, LLC. | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.